설명

A study by StrategyHelix indicates that the global clinical next-generation sequencing market is expected to increase by US$ 18.4 에서 십억 2022 에게 2028, 의 CAGR 획득 23.4% 예측 기간 동안.

이 보고서는 기간 동안 최신 시장 규모 데이터를 제공합니다. 2018-2021 그리고 예측 2028 covering key market aspects like sales value for clinical next-generation sequencing. The global clinical next-generation sequencing market is segmented on the basis of component, disease class, disease category, test complexity, test purpose, 및 지역. Based on component, the global clinical next-generation sequencing market is categorized into instrument, workflow solution (kits, 서비스, etc.). On the basis of disease class, the global clinical next-generation sequencing market has been segmented into cancer, non-cancer. The non-cancer segment captured the largest share of the market in 2021. By disease category, the global clinical next-generation sequencing market has been segmented into cardiovascular, clinical microbiology and infectious diseases, mendelian disorders, metabolic/immune, neurological, oncology, reproductive health, transplantation. 연구에 따르면, the oncology segment had the largest share in the global clinical next-generation sequencing market. Based upon test complexity, the global clinical next-generation sequencing market is categorized into hotspot, multi-gene, single gene, whole genome, whole/targeted exome. The multi-gene segment held the largest revenue share in 2021. On the basis of test purpose, the global clinical next-generation sequencing market has been segmented into diagnosis, 모니터링, screening/early detection, therapy guidance. 지리학적 측면에서, the global clinical next-generation sequencing market has been segmented into Asia Pacific, 유럽, 북아메리카, 세계의 나머지 (열).

The global clinical next-generation sequencing market is highly competitive. 현재 2021, the major players in the global clinical next-generation sequencing market were ANGLE plc, Becton Dickinson and Company, BGI 그룹, Biocept Inc., Biodesix Inc., Biolidics Limited, Bio-Techne Corporation, Burning Rock Biotech Limited, CareDx Inc., Danaher Corp., Epigenomics AG, Eurofins Scientific SE, EXACT Sciences Corporation, Fulgent Genetics Inc., GeneDx Inc., Guardant Health Inc., Illumina Inc., Koninklijke Philips N.V., Merck KGaA, 무수한 유전학 Inc., NeoGenomics Laboratories Inc., Qiagen N.V., Quest Diagnostics 통합, Roche Holding AG, 써모 피셔 사이언티픽(주).

이 보고서는 이 업계에서 활동하는 회사 및 조직에 매우 귀중한 리소스입니다.. It provides a cohesive picture of the clinical next-generation sequencing market to help drive informed decision making for industry executives, 정책 입안자, 학생, 및 분석가.

보고 범위

요소: instrument, workflow solution (kits, 서비스, etc.)
Disease class: cancer, non-cancer
Disease category: 심혈관, clinical microbiology and infectious diseases, mendelian disorders, metabolic/immune, neurological, oncology, reproductive health, transplantation
Test complexity: hotspot, multi-gene, single gene, whole genome, whole/targeted exome
Test purpose: 진단, 모니터링, screening/early detection, therapy guidance
지역: 아시아 태평양, 유럽, 북아메리카, 세계의 나머지 (열)
년 고려: 이 보고서는 기간을 다룹니다 2018 에게 2028

이해관계자를 위한 주요 이점

– Get a comprehensive picture of the global clinical next-generation sequencing market
– 로컬 데이터를 기반으로 지역 전략 및 전략적 우선 순위 식별
– 성장 분야 및 투자 동향 파악

목차

부분 1. 소개
– 연구 범위
– 공부 기간
– 지리적 범위
– 연구 방법론
부분 2. Clinical next-generation sequencing market overview
부분 3. Market breakdown by component
– Instrument
– Workflow solution (kits, 서비스, etc.)
부분 4. Market breakdown by disease class
– Cancer
– Non-cancer
부분 5. Market breakdown by disease category
– Cardiovascular
– Clinical microbiology and infectious diseases
– Mendelian disorders
– Metabolic/immune
– Neurological
– 종양학
– Reproductive health
– Transplantation
부분 6. Market breakdown by test complexity
– Hotspot
– Multi-gene
– Single gene
– Whole genome
– Whole/targeted exome
부분 7. Market breakdown by test purpose
– Diagnosis
– Monitoring
– Screening/early detection
– Therapy guidance
부분 8. 지역별 시장 분석
– 아시아 태평양
– 유럽
– 북아메리카
– 세계의 나머지 (열)
부분 9. 주요 기업
– ANGLE plc
– 벡톤, 디킨슨 앤 컴퍼니
– BGI 그룹
– Biocept, 주식회사.
– Biodesix, 주식회사.
– Biolidics Limited
– Bio-Techne Corporation
– Burning Rock Biotech Limited
– CareDx, 주식회사.
– Danaher Corp.
– Epigenomics AG
– Eurofins Scientific SE
– EXACT Sciences Corporation
– Fulgent Genetics Inc.
– GeneDx Inc.
– Guardant Health, 주식회사.
– Illumina, 주식회사.
– Koninklijke 필립스 N.V.
– Merck KGaA
– Myriad Genetics, 주식회사.
– NeoGenomics Laboratories, 주식회사.
– Qiagen N.V.
– Quest Diagnostics 통합
– Roche Holding AG
– 써모 피셔 사이언티픽(주).
스트래티지헬릭스 소개
부인 성명